The document summarizes a presentation for a medical device called the Smart Needle. It describes the Smart Needle as a patented, easy to use device that can safely and accurately deliver injections and record data to help reduce medical complications. It estimates the potential market size at over $1 billion based on the large number of procedures performed annually in Russia and the US that could benefit from the Smart Needle. The founder is seeking a $2 million first round of funding to support FDA approval and further development based on a strong team and patented technology.

1. Dmitry Shpakov Igloptika Ltd. tel . : +7 ( 911 ) 990-90-66 Skype: igloptika igloptika @mail.ru « Smart Needle » «Injection s must be safe !»

2. Epidural Space

3. Pain C hildbirth anesthesia Russia USA Loss from one complication $2,3K $ 85 K Number of operations, annual 1,5 M 3 ,2M Complications rate 1% Number of Complications 15 000 32 000 Loss $34, 5 M $ 2,72 B

9. Business-model OEMs Smart Needle USA Production , marketing , sales, support Insurance companies Physicians Hospitals , cliniks SN – Smart Needle . Igloptika, Ltd. R&D Distributors $ SN SN SN SN Marketing $ $ Feed-back Feed-back

11. Team Dmitry Shpakov – CEO Designing of optical devices (6 years), executive management. Svjatoslav Latyev – CTO PhD, Professor, Chief designer Vladimir Volchkov – Med Adviser PhD, Professor, Chief Anesthesiologist of North-West region of Russia Sergey Poduzov – Biz Adviser MIBA, 6 years in corporate finance Michael Shpakov - CIO PhD, 16 years in software development

12. Current status & Roadmap Prototype 2009 Testing prototype 2009 P re-production model 2010 PCT Patent 2010 FDA Approval 201 1-2013 Today Sertification in Russia 2011 1-st Round 2-nd Round